Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases

In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Guarav Gulsin from the University of British Columbia. They cover everything you need to know about this class of drugs for use in heart disease and beyond following the publication of a comprehensive review paper in Heart. If you enjoy the show, please subscribe to the podcast to get episodes automatically downloaded to your phone and computer. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2 Link to published paper:

https://heart.bmj.com/content/early/2021/05/09/heartjnl-2021-319185